News
Featured
Recent news

ViruSure launches first GMP-validated viral safety test based on Oxford Nanopore sequencing

Oxford Nanopore receives regulatory approval for its first diagnostic device in the UK and Europe
Appointment of Francis Van Parys as Chief Executive Officer

Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterise drug resistant-tuberculosis

Oxford Nanopore announces PromethION Plus Flow Cell and other human genetics updates at ASHG 2025

Bio-Techne and Oxford Nanopore expand agreement to accelerate development of genetics portfolio through 2032

Oxford Nanopore launches a 24-hour whole genome sequencing workflow for rare disease research

Oxford Nanopore launches Microbial Amplicon Barcoding Kit for faster, more flexible microbial profiling

Oxford Nanopore launches a comprehensive Hereditary Cancer Panel

ViruSure launches pioneering viral contamination test for biopharmaceuticals using Oxford Nanopore technology

MRC Unit The Gambia and Oxford Nanopore celebrate new Genomics Centre launch

London Calling 2025 Technology Update: Oxford Nanopore unveils path to a true multiomics future
Most read
- pioneering european collaboration to advance genetic diagnostics introducing the european long read innovation network elrin
- news r103 newest nanopore high accuracy nanopore sequencing now available store
- london calling 2025 technology update
- news blog you cant put label innovation or can you
- breakthrough towards protein sequencing using oxford nanopore holds promise for disease research and drug development



